Selected Research References Sikiric P, Seiwerth S, Rucman R, et al
Snytnikova, Olga A
Current drugs to treat Alzheimers disease Available FDA approved drugs to treat AD fall into two major classes (Table 1): 1) Namenda (memantine HCl) acts as an N-methyl-D- aspartate (NMDA) receptor antagonist designed to limit glutamate excitotoxicity and resulting neuronal damage [15-17]
Weeks 1 to 2 (loading phase): Most patients notice reduced pain and inflammation before they notice structural improvement
The 4X Blend combines GHRP-2 (5 mg) , Tesamorelin (5 mg) , MGF (500 mcg) , and Ipamorelin (2.5 mg)
Morning use may support energy, focus, and metabolism, while nighttime use may help with detoxification, sleep quality, and cellular repair